T. Aiello

发表

Infection with the Omicron variant of SARS-CoV-2 is associated with less severe disease in hospitalized patients with COVID-19

Á. Soriano, José A. Martínez, J. Mensa, 2022, Journal of Infection.

New treatments for multidrug-resistant non-fermenting Gram-negative bacilli Infections

C. García-Vidal, P. Puerta-Alcalde, M. Chumbita, 2022, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia.

Antiviral drugs against SARS-CoV-2

Á. Soriano, C. García-Vidal, T. Aiello, 2022, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia.

Bacterial Bloodstream Infections in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide.

María Teresa Solano, J. Esteve, M. Lozano, 2022, Transplantation and cellular therapy.

Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

Andrew J. Oler, Eglantine Ferrand Devouge, P. Gregersen, 2023, Genome Medicine.

Current outcomes of SARS-CoV-2 Omicron variant infection in high-risk haematological patients treated early with antivirals.

J. Esteve, Á. Soriano, J. Mensa, 2023, The Journal of antimicrobial chemotherapy.

Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

Andrew J. Oler, Eglantine Ferrand Devouge, P. Gregersen, 2023, Genome Medicine.

High Rate of Inappropriate Antibiotics in Patients with Hematologic Malignancies and Pseudomonas aeruginosa Bacteremia following International Guideline Recommendations

Á. Soriano, C. García-Vidal, C. Gudiol, 2023, Microbiology spectrum.

Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry

L. Pagano, Gina Varricchio, F. Farina, 2023, eClinicalMedicine.

Remdesivir or Nirmatrelvir/Ritonavir Therapy for Omicron SARS-CoV-2 Infection in Hematological Patients and Cell Therapy Recipients

C. Solano, J. Hernández‐Rivas, I. García-Cadenas, 2023, Viruses.

Extended remdesivir administration in haematological patients with malignancies and COVID-19 during the Omicron era: safety and outcomes.

L. Magnano, M. Suárez-Lledó, T. Aiello, 2024, The Journal of antimicrobial chemotherapy.

Omicron SARS-CoV-2 infection management and outcomes in patients with hematologic disease and recipients of cell therapy

J. Hernández‐Rivas, I. García-Cadenas, J. Piñana, 2024, Frontiers in oncology.

Reply to the Comment on Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry.

T. Aiello, C. Garcia-Vidal, 2024, Haematologica.

Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022

A. Barać, Gina Varricchio, G. Nadali, 2024, EClinicalMedicine.

Improving management of febrile neutropenia in oncology patients: the role of artificial intelligence and machine learning

T. Aiello, Patricia Monzo-Gallo, Mariana Chumbita, 2024, Expert review of anti-infective therapy.

Prevalence and impact of multidrug-resistant bacteria in solid cancer patients with bloodstream infection: a 25-year trend analysis.

C. Pitart, L. Morata, P. Puerta-Alcalde, 2024, Microbiology spectrum.

Safety and effectiveness of isavuconazole in real-life non-neutropenic patients.

P. Martín-Dávila, I. Ruiz-Camps, C. Gudiol, 2024, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.